New trends in the treatment of androgenetic alopecia

Androgenetic alopecia is the most common form of non-cicatricial hair loss, affecting a significant proportion of the population, particularly men. Due to increasing societal demands for a flawless appearance, there is an increase in pressure on physicians and specialists to provide effective and sa...

Full description

Saved in:
Bibliographic Details
Main Authors: Szymon Leonik, Michał Smoczok, Beata Bergler-Czop
Format: Article
Language:English
Published: Termedia Publishing House 2025-01-01
Series:Przegląd Dermatologiczny
Subjects:
Online Access:https://www.termedia.pl/New-trends-in-the-treatment-of-androgenetic-alopecia,56,55444,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584824117788672
author Szymon Leonik
Michał Smoczok
Beata Bergler-Czop
author_facet Szymon Leonik
Michał Smoczok
Beata Bergler-Czop
author_sort Szymon Leonik
collection DOAJ
description Androgenetic alopecia is the most common form of non-cicatricial hair loss, affecting a significant proportion of the population, particularly men. Due to increasing societal demands for a flawless appearance, there is an increase in pressure on physicians and specialists to provide effective and safe treatment for patients suffering from androgenic alopecia. However, treatments with proven efficacy approved by recognised organisations and associations are limited, and research is ongoing to discover new drugs, redesign existing ones and establish therapy algorithms. This publication reviews the use of minoxidil, 5a-reductase inhibitors (applied orally, topically and by injection), tretinoin, botulinum toxin, microRNA, and osteopontin as treatment options for androgenetic alopecia in men.
format Article
id doaj-art-d8cb9a164dde49f1977afc136bd6ba08
institution Kabale University
issn 0033-2526
2084-9893
language English
publishDate 2025-01-01
publisher Termedia Publishing House
record_format Article
series Przegląd Dermatologiczny
spelling doaj-art-d8cb9a164dde49f1977afc136bd6ba082025-01-27T11:10:28ZengTermedia Publishing HousePrzegląd Dermatologiczny0033-25262084-98932025-01-01111427327910.5114/dr.2024.14662455444New trends in the treatment of androgenetic alopeciaSzymon LeonikMichał SmoczokBeata Bergler-CzopAndrogenetic alopecia is the most common form of non-cicatricial hair loss, affecting a significant proportion of the population, particularly men. Due to increasing societal demands for a flawless appearance, there is an increase in pressure on physicians and specialists to provide effective and safe treatment for patients suffering from androgenic alopecia. However, treatments with proven efficacy approved by recognised organisations and associations are limited, and research is ongoing to discover new drugs, redesign existing ones and establish therapy algorithms. This publication reviews the use of minoxidil, 5a-reductase inhibitors (applied orally, topically and by injection), tretinoin, botulinum toxin, microRNA, and osteopontin as treatment options for androgenetic alopecia in men.https://www.termedia.pl/New-trends-in-the-treatment-of-androgenetic-alopecia,56,55444,1,1.htmlmicrorna botulinum toxin minoxidil androgenetic alopecia 5a-reductase inhibitor
spellingShingle Szymon Leonik
Michał Smoczok
Beata Bergler-Czop
New trends in the treatment of androgenetic alopecia
Przegląd Dermatologiczny
microrna
botulinum toxin
minoxidil
androgenetic alopecia
5a-reductase inhibitor
title New trends in the treatment of androgenetic alopecia
title_full New trends in the treatment of androgenetic alopecia
title_fullStr New trends in the treatment of androgenetic alopecia
title_full_unstemmed New trends in the treatment of androgenetic alopecia
title_short New trends in the treatment of androgenetic alopecia
title_sort new trends in the treatment of androgenetic alopecia
topic microrna
botulinum toxin
minoxidil
androgenetic alopecia
5a-reductase inhibitor
url https://www.termedia.pl/New-trends-in-the-treatment-of-androgenetic-alopecia,56,55444,1,1.html
work_keys_str_mv AT szymonleonik newtrendsinthetreatmentofandrogeneticalopecia
AT michałsmoczok newtrendsinthetreatmentofandrogeneticalopecia
AT beataberglerczop newtrendsinthetreatmentofandrogeneticalopecia